{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:40:49Z","timestamp":1789954849344,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jtct.2025.11.002","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T01:35:46Z","timestamp":1762392946000},"page":"358.e1-358.e14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Limited Impact of Pre-existing Rheumatologic Diseases on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Propensity\u2013Score Matched Analysis"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8378-540X","authenticated-orcid":false,"given":"Norina","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5530-6133","authenticated-orcid":false,"given":"Akihito","family":"Shinohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9827-8526","authenticated-orcid":false,"given":"Shun-Ichi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5952-5926","authenticated-orcid":false,"given":"Naoyuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7322-5460","authenticated-orcid":false,"given":"Noboru","family":"Asada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8814-230X","authenticated-orcid":false,"given":"Masatsugu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Hagihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Onizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5498-3370","authenticated-orcid":false,"given":"Yukinori","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4404-2870","authenticated-orcid":false,"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Nakasone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2025.11.002_bib0001","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.jtct.2025.11.002_bib0002","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.11.002_bib0003","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41409-021-01502-8","article-title":"Association of pre-existing comorbidities with outcome of allogeneic hematopoietic cell transplantation. A retrospective analysis from the EBMT","volume":"57","author":"Penack","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.11.002_bib0004","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/s41409-024-02395-z","article-title":"Influence of comorbidities on outcome in 1102 patients with an allogeneic hematopoietic stem cell transplantation","volume":"59","author":"Janscak","year":"2024","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.11.002_bib0005","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41409-022-01833-0","article-title":"A high hematopoietic cell transplantation comorbidity Index (HCT-CI) does not impair outcomes after non-myeloablative allogeneic stem cell transplantation in acute myeloid leukemia patients 60 years or older","volume":"58","author":"Backhaus","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.11.002_bib0006","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2015-207524","article-title":"Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force","volume":"75","author":"Smolen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtct.2025.11.002_bib0007","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13036-025-00534-8","article-title":"Targeting rheumatoid arthritis: a molecular perspective on biologic therapies and clinical progress","volume":"19","author":"Jain","year":"2025","journal-title":"J Biol Eng"},{"key":"10.1016\/j.jtct.2025.11.002_bib0008","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12185-015-1907-9","article-title":"Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation","volume":"103","author":"Kanda","year":"2016","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2025.11.002_bib0009","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12185-015-1894-x","article-title":"Introduction of transplant registry unified management program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data)","volume":"103","author":"Atsuta","year":"2016","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2025.11.002_bib0010","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1532\/IJH97.06239","article-title":"Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System","volume":"86","author":"Atsuta","year":"2007","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2025.11.002_bib0011","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/bmt.2011.110","article-title":"The EBMT risk score","volume":"47","author":"Gratwohl","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.11.002_bib0012","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jtct.2025.11.002_bib0013","article-title":"PSMATCH2: Stata module to perform full Mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing","author":"Leuven","year":"2003","journal-title":"EconPapers"},{"key":"10.1016\/j.jtct.2025.11.002_bib0014","first-page":"825","article-title":"1994 consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.11.002_bib0015","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients","volume":"69","author":"Shulman","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.jtct.2025.11.002_bib0016","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"EL Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.jtct.2025.11.002_bib0017","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"key":"10.1016\/j.jtct.2025.11.002_bib0018","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.jtct.2025.11.002_bib0019","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.11.002_bib0020","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/bmt.2015.330","article-title":"Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantation","volume":"51","author":"Tanaka","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.11.002_bib0021","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/cncr.31310","article-title":"T-cell-depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: a study from the acute leukemia working party of the European Society of Blood and Marrow Transplantation (EBMT)","volume":"124","author":"Sestili","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2025.11.002_bib0022","doi-asserted-by":"crossref","first-page":"vi12","DOI":"10.1093\/rheumatology\/keab609","article-title":"Recent progress in treatments of rheumatoid arthritis: an overview of developments in biologics and small molecules, and remaining unmet needs","volume":"60","author":"Tanaka","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jtct.2025.11.002_bib0023","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/BOR.0b013e32834518a3","article-title":"Pathophysiology of rheumatoid arthritis","volume":"23","author":"Cooles","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jtct.2025.11.002_bib0024","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and management of rheumatoid arthritis: a review","volume":"320","author":"Aletaha","year":"2018","journal-title":"Jama"},{"key":"10.1016\/j.jtct.2025.11.002_bib0025","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/ard.2009.123919","article-title":"Treating rheumatoid arthritis to target: recommendations of an international task force","volume":"69","author":"Smolen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtct.2025.11.002_bib0026","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1136\/annrheumdis-2015-207726","article-title":"Definition and initial validation of a lupus low disease activity state (LLDAS)","volume":"75","author":"Franklyn","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtct.2025.11.002_bib0027","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.autrev.2014.01.055","article-title":"Optimizing outcome in SLE: treating-to-target and definition of treatment goals","volume":"13","author":"Doria","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jtct.2025.11.002_bib0028","first-page":"52","article-title":"GRAPPA treatment recommendations: 2021 update","volume":"49","author":"Coates","year":"2022","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jtct.2025.11.002_bib0029","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2017-211734","article-title":"Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force","volume":"77","author":"Smolen","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtct.2025.11.002_bib0030","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/rheumatology\/keu288","article-title":"Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards","volume":"54","author":"Khanna","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jtct.2025.11.002_bib0031","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(12)61079-4","article-title":"Interstitial lung disease in connective tissue disorders","volume":"380","author":"Fischer","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jtct.2025.11.002_bib0032","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001263","article-title":"Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations","volume":"6","author":"Kostopoulou","year":"2020","journal-title":"RMD Open"},{"key":"10.1016\/j.jtct.2025.11.002_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102427","article-title":"Coronary artery disease in systemic lupus: a case-controlled angiographic study","volume":"19","author":"Chazal","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jtct.2025.11.002_bib0034","doi-asserted-by":"crossref","first-page":"6825","DOI":"10.1038\/s41598-018-24060-4","article-title":"In-patient outcomes of hematopoietic stem cell transplantation in patients with immune mediated inflammatory diseases: a nationwide study","volume":"8","author":"Mehta","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtct.2025.11.002_bib0035","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/bloodadvances.2025015793","article-title":"Novel composite health assessment risk model for older allogeneic transplant recipients: BMT-CTN 1704","volume":"9","author":"Sorror","year":"2025","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2025.11.002_bib0036","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s00277-024-05772-2","article-title":"Systemic inflammatory autoimmune disease before allogeneic hematopoietic stem cell transplantation is a risk factor for death in patients with myelodysplastic syndrome or chronic myelomonocytic leukemia","volume":"103","author":"Tazoe","year":"2024","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2025.11.002_bib0037","first-page":"1","article-title":"The evolving role of blood and marrow transplantation for the treatment of autoimmune diseases","volume":"48","author":"Sullivan","year":"1997","journal-title":"J Rheumatol Suppl"},{"key":"10.1016\/j.jtct.2025.11.002_bib0038","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/ard.60.7.702","article-title":"Haemopoietic stem cell transplantation in the treatment of severe autoimmune diseases 2000","volume":"60","author":"Tyndall","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtct.2025.11.002_bib0039","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/S2352-3026(23)00342-3","article-title":"Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation","volume":"11","author":"Penack","year":"2024","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtct.2025.11.002_bib0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41408-024-01032-8","article-title":"PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation","volume":"14","author":"Penack","year":"2024","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jtct.2025.11.002_bib0041","doi-asserted-by":"crossref","DOI":"10.1038\/s41409-025-02692-1","article-title":"Improved GVHD-free relapse-free survival when rATG\/ATLG is used in allo-HCT from matched sibling donors: an EBMT registry study by the transplant complications working party","author":"Piekarska","year":"2025","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.11.002_bib0042","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.bbmt.2013.05.020","article-title":"Significance of ethnicity in the risk of acute graft-versus-host disease and leukemia relapse after unrelated donor hematopoietic stem cell transplantation","volume":"19","author":"Morishima","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.11.002_bib0043","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.bbmt.2015.12.027","article-title":"Graft-versus-host disease after HLA-matched sibling bone marrow or peripheral blood stem cell transplantation: comparison of north american caucasian and japanese populations","volume":"22","author":"Kanda","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.11.002_bib0044","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1182\/bloodadvances.2019000386","article-title":"Comparison of characteristics and outcomes of late acute and NIH chronic GVHD between Japanese and white patients","volume":"3","author":"Inamoto","year":"2019","journal-title":"Blood Adv"}],"updated-by":[{"DOI":"10.1016\/j.jtct.2025.11.002","type":"removal","label":"Removal","source":"publisher","updated":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000}}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725015507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725015507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T03:29:55Z","timestamp":1775100595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725015507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2666636725015507"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.11.002","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Limited Impact of Pre-existing Rheumatologic Diseases on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Propensity\u2013Score Matched Analysis","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Transplantation and Cellular Therapy. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}